Financials

  • Market Capitalization 9.64 M
  • Employee 16
  • Founded 1986
  • CEO N/A
  • Website www.therivabio.com
  • Headquarter Nevada, United States
  • FIGI BBG000BV6QX8
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-0.34
Rapporto prezzo/fatturato
17.45

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4758
VTGN
Vistagen Therapeutics, Inc. - Common Stock
0.24 USD0.00%+9.09%+9.09%-53.41%9.85 M USD
4762
CRIS
Curis, Inc. - Common Stock
5.17 USD+4.23%+3.82%+894.23%+211.45%10.08 M USD
4773
LSTA
Lisata Therapeutics, Inc. - Common Stock
1.08 USD+4.85%-48.33%-67.95%-56.28%9.83 M USD
4780
LNAI
Lunai Bioworks Inc. - Common Stock
2.02 USD-4.27%-15.48%-38.41%+30.32%9.16 M USD

Notizie